Gan & Lee Pharmaceuticals' (SHA:603087) net profit attributable to shareholders in the first half rose 1% to 609.8 million yuan from 603.7 million yuan a year earlier, according to a Shanghai bourse filing on Wednesday.
Earnings per share grew year on year to 1.03 yuan from 1.02 yuan.
Operating revenue increased 7.6% to 2.22 billion yuan from 2.07 billion yuan in the previous year.
The Chinese pharmaceutical company's shares closed 4% higher.